New human data hints at psychedelics' potential to combat inflammation

Researchers have published new human data indicating that psychedelics may help combat inflammation in patients with neurodegenerative conditions such as Parkinson's disease. Previous laboratory studies had already demonstrated that substances like psilocybin possess the ability to lower inflammation and offer potential protection against a range of illnesses. This latest release represents some of the first data gathered directly from humans suggesting those protective and anti-inflammatory properties hold clinical potential.